ClinicoEconomics and outcomes research : CEOR | 30 Nov 2016
LM Moura, EL Schwamm, V Moura Junior, MP Seitz, DB Hoch, J Hsu and LH Schwamm
Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders.
* Data courtesy of Altmetric.com